BRAINTRANSPORTER
LIVE

Serial Number

98494527

Owner

BioArctic AB

Attorney

Jessica S. Sachs

Filing Date

Apr 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BRAINTRANSPORTER Trademark

Serial Number: 98494527

BRAINTRANSPORTER is a trademark filed by BioArctic AB on April 11, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BioArctic AB (3 trademarks)

Warfvinges väg 35
Stockholm 11251 , SE

Entity Type: 99

Trademark Details

Filing Date

April 11, 2024

Registration Date

Not Registered

Published for Opposition

May 6, 2025

Goods & Services

(Based on Intent to Use) Medical and veterinary preparations for the treatment of disorders of the central nervous system; Medical and veterinary articles namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations and substances for the treatment of disorders of the central nervous system; biochemical preparations for medical use for the treatment of the central nervous system; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes for diagnostic testing relating to disorders of the central nervous system; diagnostic preparations and materials for medical or veterinary purposes; medical therapeutic agents for the central nervous system; reagents for medical use; biochemical biomarkers for medical use; diagnostic biomarker reagents for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) live organs and tissues for surgical implantation purpose; (Based on Intent to Use) cells for medical use; stem cells for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) sanitary preparations for medial purposes; (Based on Intent to Use) dietetic substances, namely dietetic foods, adapted for medical purposes

(Based on Intent to Use) Chemical substances, chemical materials and chemical preparations, and natural biological preparation elements for use in manufacture of pharmaceuticals; chemical substances and materials for industrial, scientific and laboratory use other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemical substances being biochemical preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting or verification use other than for medical use; reagents other than for medical or veterinary purposes for use in the development of antibodies for scientific and medical research use; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicals, except for medical or veterinary use being antibodies and antibodies-based chemicals for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use

(Based on Intent to Use) scientific and technological services and research, namely, scientific research relating to product development and design in the field of central nervous system disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 8, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 10, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 19, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 13, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2024 NWOS
NEW APPLICATION ENTERED
Apr 11, 2024 NWAP